祛湿驱寒方联合甲氨蝶呤、来氟米特熏洗治疗类风湿性关节炎寒湿痹证疗效观察
作者:
作者单位:

江西省人民医院康复医学科,南昌330000,江西,中国

作者简介:

通讯作者:

中图分类号:

基金项目:


Efficacy of TCM Fumigation Using Dampness-and-cold-dispelling Formula Combined with Methotrexate and Leflunomide Treating Rheumatoid Arthritis with Cold-dampness Bi Syndrome
Author:
Affiliation:

Department of Rehabilitation Medicine, Jiangxi Provincial People's Hospital,The First Affiliated Hospital of Nanchang Medical College, 330000 Nanchang, Jiangxi, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    背景:类风湿性关节炎(Rheumatoid arthritis, RA)是一种慢性自身免疫性疾病,发病率高,致残率高,患者不适明显。目前尽管可以采用药物缓解,但具有明显的副作用。熏蒸是最常用的中医外治法之一。该研究将临床药物治疗与中医熏蒸疗法相结合,以提高患者的临床疗效,缓解症状,改善预后。目的:探讨中西医结合治疗寒湿痹证类风湿性关节炎的疗效。方法:设计单中心、随机对照研究。2022年1月至2022年12月,共纳入60例RA寒湿痹证患者。对照组(30例)采用常规治疗药甲氨蝶呤治疗4周,观察组(30例)采用中药熏洗与常规治疗药联合治疗4周。综合比较两组治疗前后中医症状评分和实验室指标的变化,以及视觉模拟量表(VAS)和健康状况评定量表(HAQ)的使用情况。结果: 观察组总有效率为93.3%,显著高于对照组的70%(P <0.05)。治疗前,两组患者关节功能活动度、疼痛视觉模拟评分(VAS)、健康评估问卷(HAQ-DI)及实验室指标比较,差异均无统计学意义(P >0.05)。治疗后,各组患者关节功能活动较初始状态均有明显改善,VAS、HAQ-DI、RA相关生物指标均显著降低(P <0.05);各组间比较显示,中药熏洗联合治疗对RA相关生物标志物和关节功能活性的影响进一步显著增强(P <0.05),但VAS和HAQ-DI的改善效果仅接受甲氨蝶呤治疗的对照组表现更好。结论:祛湿驱寒方熏洗联合治疗寒湿痹证类风湿性关节炎疗效确切,并能提高患者的生活质量,改善关节功能,减少炎症。

    Abstract:

    Background Rheumatoid arthritis (RA), a chronic autoimmune disease, has a high incidence and disability rate, causing patients significant discomfort. Although several medicines can be effective, they are also associated with significant adverse effects. In contrast, fumigation as one of the most often used traditional Chinese medicine (TCM) external therapy has shown both efficacy and safety with less side effect. In light of this, we complement western medicine treatment with TCM fumigation therapy to improve patients' clinical efficacy, alleviate symptoms, and improve prognosis. Objective To investigate the therapeutic effect of TCM fumigation and modern medicine combined therapy in treating RA patients with cold-dampness Bi syndrome. Methods A single-center, randomized, controlled study was designed. From January 2022 to December 2022, a total of 60 RA patients with cold-dampness Bi syndrome were enrolled in the study. The control group (30 cases) received conventional modern medicine treatment with methotrexate for 4 weeks, while the observation group (30 cases) for 4 weeks received a combination of TCM fumigation treatment and conventional modern medicine. The effects of the two groups were comprehensively compared, including the changes in TCM symptom scores and laboratory indicators, as well as the use of visual analogue scale (VAS) and health status rating scale (HAQ) before and after treatment. Results The total effective rate of the observation group was 93.3%, which was significantly higher than that of the control group, which is 70% (P < 0.05). Before treatment, there were no significant differences in joint functional activity, pain visual analogue scale (VAS), health assessment questionnaire (HAQ-DI) and laboratory indexes between the two groups (P > 0.05). After treatment, each group compared to their initial condition, respectively, showed major improvement of joint functional activity and significantly decreased VAS, HAQ-DI, and RA-related biomarkers (P < 0.05); inter-group comparison of these indicators showed significanty further enhanced effect of TCM fumigation combined therapy on the RA-related biomarkers and joint functional activity of patients (P < 0.05), yet the control group receiving only modern medicine showed better results of the VAS and HAQ-DI . Conclusion The TCM fumigation combined therapy is effective to treat RA patients with cold-dampness Bi syndrome, and to enhance their life quality, improving the joint function, and reducing inflammation.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-04-15
  • 出版日期: